Morfea en placas inducidas por paclitaxel

Torregrosa, Jose Luis; Fernandez, M. Teresa Funes; Garcías, Juan; Pérez, Amparo Sancho

doi:10.1016/j.medcli.2013.06.023

Medicina Clínica

2014

DOI: 10.1016/j.medcli.2013.06.023

|View full text |Cite

Morfea en placas inducidas por paclitaxel

Jose Luis Torregrosa¹,

M. Teresa Funes Fernandez²,

Juan Garcías³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2014

2018

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to published reports, several cases of scleroderma/pseudoscleroderma have been induced by taxane therapy while some cases have demonstrated the presence of ANA-Hep2 antibodies [ 1 – 3 ]. Only one case report describes involvement of gemcitabine [ 4 ].…”

mentioning

confidence: 99%

The first case of drug-induced pseudoscleroderma and eczema craquelé related to nab-paclitaxel pancreatic adenocarcinoma treatment

Sokołowska‐Wojdyło¹,

Kłudkowska²,

Olszewska³

et al. 2018

pdia

View full text Add to dashboard Cite

mentioning

confidence: 99%

The first case of drug-induced pseudoscleroderma and eczema craquelé related to nab-paclitaxel pancreatic adenocarcinoma treatment

Sokołowska‐Wojdyło¹,

Kłudkowska²,

Olszewska³

et al. 2018

pdia

View full text Add to dashboard Cite

Paclitaxel

2014

Reactions Weekly

View full text Add to dashboard Cite

Localized Scleroderma: Predisposing and Triggering Factors

Хамаганова¹

2017

TODJ

View full text Add to dashboard Cite

Abstract:The etiology of localized scleroderma remains unclear. The objective of this article is to review different theories of etiology, specifically provocative and predisposing factors for the development of localized scleroderma. The mini-review presents the factors, which may influence the occurrence of localized scleroderma. The genetic predisposition for the development of scleroderma is a relevant characteristic of the disease. Different traumatic factors, viral & bacterial infections, chemical substances, pharmaceutical agents may trigger localized scleroderma. Neoplasia is regarded as a distinct triggering impulse for scleroderma.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Morfea en placas inducidas por paclitaxel

Cited by 3 publications

References 9 publications

The first case of drug-induced pseudoscleroderma and eczema craquelé related to nab-paclitaxel pancreatic adenocarcinoma treatment

The first case of drug-induced pseudoscleroderma and eczema craquelé related to nab-paclitaxel pancreatic adenocarcinoma treatment

Paclitaxel

Localized Scleroderma: Predisposing and Triggering Factors

Contact Info

Product

Resources

About